Skip to main content

Oklahoma Opioid Lawsuits: Ruling Expected On Monday

Oklahoma Opioid Lawsuits: Ruling Expected On Monday

Oklahoma Opioid Lawsuits: Ruling Expected On Monday

Introduction

Cleveland County District Judge Thad Balkman in Norman, Oklahoma, will be ruling a judgment on Monday deciding whether Johnson & Johnson (J&J) should be held liable for the Oklahoma opioid epidemic.

The judge will give the decision after presiding over the first trial of the thousands of lawsuits brought by the state’s attorney general, arguing that the drugmaker should be forced to pay $17 billion for fueling the opioid epidemic.

The case is being closely watched by plaintiffs in other opioid lawsuits, especially the cases pending in Ohio. Purdue Pharma LP and Teva Pharmaceutical Industries Ltd, who also were defendants in the case, made a settlement of $270 million in March and $85 million in May respectively, denying any wrongdoing.

Allegations include that the drug manufacturers were involved in deceptive marketing for years without highlighting the addiction risks associated with opioids, and recklessly selling the powerful pain medications.

According to the U.S. Centers for Disease Control and Prevention, 400,000 opioid overdose deaths were reported from 1999 to 2017. Around 6,000 Oklahomans have died from opioid overdoses since 2000, as per the state's lawyers. 

Federal health officials warned that opioids account for nearly 70% of all drug overdoses. In the year 2013, 3100 died due to opioid overdoses and the number is expected to increase more than 36,000 by end of 2019.

A case for the opioid crisis that began in 2014 was the first in history where local government entities sued Big Pharma for causing painkiller addiction. The case induced for the Oklahoma opioid epidemic this year is the first to go for trial. 

Opioid lawsuits are consolidated under MDL No. 2804 (In Re: National Prescription Opiate Litigation) presided by Judge Dan Polster.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!